LPCN (STOCKS)
Lipocine Inc.
$2.290000
+0.030000 (+1.33%)
Prev close: $2.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mahesh V. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.88M
- Employees
- 16
- P/E (TTM)
- -1.17
- P/B (TTM)
- 0.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.54 | $-0.49 | -0.0453 | -9.16% |
|
Dec 2025 (Q4)
|
$-0.42 | $-0.62 | +0.2022 | +32.50% |
|
Sep 2025 (Q3)
|
$-0.59 | $-0.55 | -0.0392 | -7.12% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.41 | -0.0020 | -0.49% |
Financial Statements
| Revenues | $2.00M |
| Benefits Costs and Expenses | $13.44M |
| Costs And Expenses | $13.01M |
| Nonoperating Income/Loss | $696.13K |
| Operating Expenses | $14.13M |
| Depreciation and Amortization | $60.03K |
| Research and Development | $10.29M |
| Other Operating Expenses | $3.82M |
| Operating Income/Loss | -$12.13M |
| Income/Loss From Continuing Operations After Tax | -$11.43M |
| Income/Loss From Continuing Operations Before Tax | -$11.43M |
| Net Income/Loss | -$11.43M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 17,637,521 |
| Diluted Average Shares | 17,896,888 |
| Assets | $25.36M |
| Current Assets | $25.24M |
| Noncurrent Assets | $113.23K |
| Fixed Assets | $89.48K |
| Other Non-current Assets | $23.75K |
| Liabilities | $2.53M |
| Current Liabilities | $2.53M |
| Accounts Payable | $1.56M |
| Other Current Liabilities | $965.12K |
| Noncurrent Liabilities | $0.00 |
| Equity | $22.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $22.83M |
| Liabilities And Equity | $25.36M |
| Net Cash Flow From Operating Activities | -$10.05M |
| Net Cash Flow From Operating Activities, Continuing | -$10.05M |
| Net Cash Flow From Investing Activities | -$3.13M |
| Net Cash Flow From Investing Activities, Continuing | -$3.13M |
| Net Cash Flow From Financing Activities | $12.18M |
| Net Cash Flow From Financing Activities, Continuing | $12.18M |
| Net Cash Flow | -$1.00M |
| Net Cash Flow, Continuing | -$1.00M |
| Comprehensive Income/Loss | -$11.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.45M |
| Other Comprehensive Income/Loss | -$11.45M |